Sciencast Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,666
Closed -$431K 461
2022
Q1
$431K Buy
+7,666
New +$400K 0.1% 252
2021
Q3
Sell
-15,638
Closed -$1.01M 441
2021
Q2
$1.01M Buy
+15,638
New +$1.04M 0.21% 141
2021
Q1
Sell
-8,561
Closed -$588K 540
2020
Q4
$588K Buy
+8,561
New +$504K 0.12% 246
2020
Q3
Sell
-10,461
Closed -$518K 437
2020
Q2
$518K Buy
+10,461
New +$564K 0.13% 251
2020
Q1
Sell
-7,658
Closed -$419K 381
2019
Q4
$419K Buy
+7,658
New +$416K 0.11% 285
2019
Q2
Sell
-14,204
Closed -$687K 332
2019
Q1
$687K Buy
+14,204
New +$720K 0.24% 134
2018
Q4
Sell
-9,167
Closed -$538K 260
2018
Q3
$538K Buy
+9,167
New +$557K 0.36% 105
2017
Q3
Sell
-8,422
Closed -$324K 358
2017
Q2
$324K Buy
+8,422
New +$308K 0.18% 215

Other funds holding EHC

Sciencast Management's EHC Position: Q2 2022 in Review

Sciencast Management sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 7,666 shares — an estimated $431K sold.

Sciencast Management first reported a position in EHC in Q2 2017 and held it in 8 quarters. The position peaked at $1.01M in Q2 2021. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • Sciencast Management reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 7,666 Encompass Health shares in Q2 2022, an estimated $431K.
  • Sciencast Management first reported a position in Encompass Health in Q2 2017 and held it in 8 quarters.
  • Sciencast Management's Encompass Health position peaked at $1.01M in Q2 2021.
  • 394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.